Month: November 2020

Nov 18 2020

Uncategorized

Global Schizophrenia Market to 2030 – Insights, Epidemiology and Market Forecast – ResearchAndMarkets.com

by Clinical Editor

No Comments

Market Insights, Epidemiology and Market Forecast – 2030″ drug pipelines has been added to ResearchAndMarkets.com’s offering.

Nov 18 2020

Uncategorized

U.S. FDA declines to approve Alkermes’ schizophrenia treatment

by Clinical Editor

No Comments

The U.S. Food and Drug Administration has declined to approve Alkermes’ treatment for schizophrenia and bipolar disorder, the drugmaker said on Tuesday.

Nov 18 2020

Uncategorized

Rare and Possibly Life-Threatening Sensitivity to Key Schizophrenia Tx

by Clinical Editor

No Comments

A 22-year-old Hispanic man with schizophrenia is placed on an involuntary hold and admitted to an inpatient psychiatric unit in California after experiencing auditory, visual, and tactile …

Nov 18 2020

Uncategorized

Improving the Design of Clinical Trials of Drugs to Treat Schizophrenia

by Clinical Editor

No Comments

CDER research has identified ways to streamline schizophrenia drug trials without compromising their sensitivity.

Nov 17 2020

Uncategorized

Global Schizophrenia Market to 2030 – Insights, Epidemiology and Market Forecast – ResearchAndMarkets.com – Yahoo Finance

by Clinical Editor

No Comments

Global Schizophrenia Market to 2030 – Insights, Epidemiology and Market Forecast – ResearchAndMarkets.com  Yahoo Finance

Nov 17 2020

Uncategorized

Global Schizophrenia Market to 2030 – Insights, Epidemiology and Market Forecast – ResearchAndMarkets.com

by Clinical Editor

No Comments

Market Insights, Epidemiology and Market Forecast – 2030″ drug pipelines has been added to ResearchAndMarkets.com’s offering.

Nov 17 2020

Uncategorized

Feinstein Institutes Researchers Help Lead $52M Study of Schizophrenia in High-Risk Youth

by Clinical Editor

No Comments

Researchers from The Feinstein Institutes for Medical Research and two other institutions have been awarded a $52 million, five-year grant from the National Institute of Mental Health (NIMH) to lead...

Nov 17 2020

Uncategorized

HLS Therapeutics Announces Health Canada Approval of PERSERIS® for the Treatment of Schizophrenia

by Clinical Editor

No Comments

first once-monthly risperidone long-acting injectable used in the treatment of schizophreniaonce-monthly dosing may help improve treatment …

Nov 17 2020

Uncategorized

Rare and Possibly Life-Threatening Sensitivity to Key Schizophrenia Tx

by Clinical Editor

No Comments

A 22-year-old Hispanic man with schizophrenia is placed on an involuntary hold and admitted to an inpatient psychiatric unit in California after experiencing auditory, visual, and tactile …

Nov 17 2020

Uncategorized

Parasite infection discovery could help develop treatments for neurological disorders

by Clinical Editor

No Comments

New research into how a common parasite infection alters human behavior could help development of treatments for schizophrenia and other neurological disorders.